{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T08:59:46Z","timestamp":1770973186009,"version":"3.50.1"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T00:00:00Z","timestamp":1705536000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.radonc.2023.110027","type":"journal-article","created":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T11:29:14Z","timestamp":1700825354000},"page":"110027","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["The feasibility of level Ib-sparing intensity-modulated radiation therapy in patients with nasopharyngeal carcinoma and high-risk factors classified based on the International Guideline"],"prefix":"10.1016","volume":"191","author":[{"given":"Zhen","family":"Meng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pian","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heqing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huan","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yating","family":"Qin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Bin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuangyue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinghua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2023.110027_b0005","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1186\/s12889-022-13688-7","article-title":"Incidence and mortality trends of nasopharynx cancer from 1990 to 2019 in China: an age-period-cohort analysis","volume":"22","author":"Bai","year":"2022","journal-title":"BMC Public Health"},{"key":"10.1016\/j.radonc.2023.110027_b0010","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1634\/theoncologist.2017-0577","article-title":"10-Year results of therapeutic ratio by intensity-modulated radiotherapy versus two-dimensional radiotherapy in patients with nasopharyngeal carcinoma","volume":"24","author":"Chen","year":"2019","journal-title":"Oncologist"},{"key":"10.1016\/j.radonc.2023.110027_b0015","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.ijrobp.2017.11.004","article-title":"Delineation of neck clinical target volume specific to nasopharyngeal carcinoma based on lymph node distribution and the international consensus guidelines","volume":"100","author":"Lin","year":"2018","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.radonc.2023.110027_b0020","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.radonc.2022.11.007","article-title":"Prognostic value of the cervical lymph node necrosis ratio in nasopharyngeal carcinoma","volume":"177","author":"Bin","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.110027_b0025","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ijrobp.2012.09.003","article-title":"Proposed lymph node staging system using the International Consensus Guidelines for lymph node levels is predictive for nasopharyngeal carcinoma patients from endemic areas treated with intensity modulated radiation therapy","volume":"86","author":"Li","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.110027_b0030","doi-asserted-by":"crossref","first-page":"993","DOI":"10.7150\/jca.17858","article-title":"Long-term patterns of regional failure for nasopharyngeal carcinoma following intensity-modulated radiation therapy","volume":"8","author":"Xue","year":"2017","journal-title":"J Cancer"},{"key":"10.1016\/j.radonc.2023.110027_b0035","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.radonc.2021.12.032","article-title":"Level Ib sparing intensity-modulated radiation therapy in selected nasopharyngeal carcinoma patients based on the International Guideline","volume":"167","author":"Guo","year":"2022","journal-title":"Radiother Oncol J Eur Soc Ther Radiol Oncol"},{"key":"10.1016\/j.radonc.2023.110027_b0040","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1186\/s12885-015-1669-z","article-title":"Investigation of the feasibility of elective irradiation to neck level Ib using intensity-modulated radiotherapy for patients with nasopharyngeal carcinoma: a retrospective analysis","volume":"15","author":"Zhang","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.radonc.2023.110027_b0045","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.radonc.2022.04.026","article-title":"Level Ib CTV delineation in nasopharyngeal carcinoma based on lymph node distribution and topographic anatomy","volume":"172","author":"Zhao","year":"2022","journal-title":"Radiother Oncol J Eur Soc Ther Radiol Oncol"},{"key":"10.1016\/j.radonc.2023.110027_b0050","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.ijrobp.2004.05.022","article-title":"Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience","volume":"60","author":"Kam","year":"2004","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.radonc.2023.110027_b0055","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.radonc.2017.10.032","article-title":"International guideline for the delineation of the clinical target volumes (CTV) for nasopharyngeal carcinoma","volume":"126","author":"Lee","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.110027_b0060","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.2147\/CMAR.S252047","article-title":"A nomogram for the prognosis of nasopharyngeal carcinoma with MR imaging-detected tumor residue at the end of intensity-modulated radiotherapy","volume":"12","author":"Xu","year":"2020","journal-title":"Cancer Manage Res"},{"key":"10.1016\/j.radonc.2023.110027_b0065","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.radonc.2022.11.005","article-title":"Neck level Ib-sparing versus level Ib-irradiation in intensity-modulated radiotherapy for the treatment of nasopharyngeal carcinoma with high-risk factors: a propensity score-matched cohort study","volume":"177","author":"Wang","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.110027_b0070","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.oraloncology.2017.11.002","article-title":"Prognostic value of masticatory muscle involvement in nasopharyngeal carcinoma patients treated with intensity-modulated radiation therapy","volume":"75","author":"Kang","year":"2017","journal-title":"Oral Oncol"},{"key":"10.1016\/j.radonc.2023.110027_b0075","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.radonc.2013.10.010","article-title":"Delineation of the neck node levels for head and neck tumors: a 2013 update. DAHANCA, EORTC, HKNPCSG, NCIC CTG, NCRI, RTOG, TROG consensus guidelines","volume":"110","author":"Gr\u00e9goire","year":"2014","journal-title":"Radiother Oncol J Eur Soc Ther Radiol Oncol"},{"key":"10.1016\/j.radonc.2023.110027_b0080","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1148\/radiology.177.2.2217772","article-title":"Cervical lymph node metastasis: assessment of radiologic criteria","volume":"177","author":"van den Brekel","year":"1990","journal-title":"Radiology"},{"key":"10.1016\/j.radonc.2023.110027_b0085","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.radonc.2021.01.015","article-title":"Unambiguous advanced radiologic extranodal extension determined by MRI predicts worse outcomes in nasopharyngeal carcinoma: potential improvement for future editions of N category systems","volume":"157","author":"Mao","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.110027_b0090","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/S1470-2045(11)70303-5","article-title":"Addition of bevacizumab to standard chemoradiation for locoregionally advanced nasopharyngeal carcinoma (RTOG 0615): a phase 2 multi-institutional trial","volume":"13","author":"Lee","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2023.110027_b0095","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1200\/JCO.2008.19.9109","article-title":"Intensity-modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: radiation therapy oncology group phase II trial 0225","volume":"27","author":"Lee","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2023.110027_b0100","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1007\/s10147-013-0650-6","article-title":"Sparing level Ib lymph nodes by intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma","volume":"19","author":"Chen","year":"2014","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.radonc.2023.110027_b0105","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3857\/roj.2022.00346","article-title":"Feasibility and safety of neck level IB-sparing radiotherapy in nasopharyngeal cancer: a long-term single institution analysis","volume":"40","author":"Kim","year":"2022","journal-title":"Radiat Oncol J"},{"key":"10.1016\/j.radonc.2023.110027_b0110","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/j.ijom.2017.11.019","article-title":"Determinants of level Ib involvement in oral squamous cell carcinoma and implications for submandibular gland-sparing neck dissection","volume":"47","author":"Subramaniam","year":"2018","journal-title":"Int J Oral Maxillofac Surg"},{"key":"10.1016\/j.radonc.2023.110027_b0120","first-page":"983","article-title":"Risk factors of level Ib lymphadenopathy in nasopharyngeal carcinoma","volume":"34","author":"Yuan","year":"2014","journal-title":"Nan Fang Yi Ke Xue Xue Bao"},{"key":"10.1016\/j.radonc.2023.110027_b0125","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s13014-017-0869-x","article-title":"The feasibility analysis of omission of elective irradiation to level IB lymph nodes in low-risk nasopharyngeal carcinoma based on the 2013 updated consensus guideline for neck nodal levels","volume":"12","author":"Ou","year":"2017","journal-title":"Radiat Oncol Lond Engl"},{"key":"10.1016\/j.radonc.2023.110027_b0130","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20150621","article-title":"Effects of omitting elective neck irradiation to nodal Level IB in nasopharyngeal carcinoma patients with negative Level IB lymph nodes treated by intensity-modulated radiotherapy: a Phase 2 study","volume":"89","author":"Li","year":"2016","journal-title":"Br J Radiol"},{"key":"10.1016\/j.radonc.2023.110027_b0135","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.radonc.2019.05.023","article-title":"Clinical and dosimetric predictors of physician and patient reported xerostomia following intensity modulated radiotherapy for nasopharyngeal cancer \u2013 A prospective cohort analysis","volume":"138","author":"Sommat","year":"2019","journal-title":"Radiother Oncol"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814023093349?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814023093349?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T05:26:03Z","timestamp":1759123563000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814023093349"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":26,"alternative-id":["S0167814023093349"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2023.110027","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The feasibility of level Ib-sparing intensity-modulated radiation therapy in patients with nasopharyngeal carcinoma and high-risk factors classified based on the International Guideline","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2023.110027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"110027"}}